Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses

Abstract

Faecalibacterium prausnitzii strain A2-165 was previously reported to have anti-inflammatory properties and prevent colitis in a TNBS model. We compared the immunomodulatory properties of strain A2-165 to four different F. prausnitzii isolates and eight abundant intestinal commensals using human dendritic cells (DCs) and mouse BMDCs in vitro. Principal component analysis revealed that the cytokine response to F. prausnitzii A2-165 is distinct from the other strains in eliciting high amounts of IL-10 secretion. The mouse DNBS model of relapsing IBD was used to compare the protective effects of F. prausnitzii A2-165 and Clostridium hathewayi, a low secretor of IL-10, on the Th1-driven inflammatory response to DNBS; attenuation of disease parameters was only observed with F. prausnitzii. In an in vivo mouse model of nasal tolerance to ovalbumin, F. prausnitzii A2-165 enhanced ovalbumin-specific T cell proliferation and reduced the proportion of IFN-γ⁺ T cells in CLNs. Similarly, in vitro F. prausnitzii A2-165 stimulated BMDCs increased ovalbumin-specific T cell proliferation and reduced the number of IFN-γ⁺ T cells. These mechanisms may contribute to the anti-inflammatory effects of F. prausnitzii in colitis and support the notion that this abundant bacterium might contribute to immune homeostasis in the intestine via its anti-inflammatory properties.

The human gastrointestinal tract is colonized by several hundred different species of commensal bacteria, referred to as the microbiota, which reaches densities of 10¹² bacteria per gram of luminal content in the colon¹,². Major changes in the microbiota are associated with a number of intestinal-related disorders including inflammatory bowel disease (IBD), irritable bowel syndrome, autoimmune disease, diabetes and colorectal cancer³.

In the healthy intestine, commensal bacteria are predominantly compartmentalized to the lumen, but can interact with immune cells associated with the epithelium or in mucosa-associated lymphoid tissues such as Peyer’s patches (PPs) or gut-draining mesenteric lymph nodes (MLNs). At these sites, antigen-presenting cells (APCs), such as dendritic cells (DCs), can sample microbes and food proteins and prime mucosal naive T cells driving their activation, clonal expansion and differentiation. In steady-state conditions, regulatory T cell (Treg) conversion in response to the presentation of harmless protein antigens occurs with a higher frequency in PPs and MLNs when compared to non-mucosa-draining lymphoid tissue. It has long been known that this preferential tolerance induction at mucosal sites is dependent on microbial sensing⁴,⁵.

Over the past years, it has become apparent that not all components of the microbiota are equal in terms of their impact on host physiology. For example, colonization of germ-free mice with the mouse commensal segmented filamentous bacteria induces an increase in the number of CD4⁺ T cells, in particular T helper 1 cells (Th1), Th17 and Foxp3⁺ Tregs in the small intestine and colon⁶. Conversely, colonization of germ-free mice with 17 Clostridia isolated from the human microbiota induced Tregs expansion and differentiation by inducing an increase in TGF-β⁷. Accumulation of colonic IL-10 secreting, Foxp3⁺ Tregs is also induced by colonization of germ-free mice with Bacteroides fragilis⁸. This implies that commensal bacteria may act upon mucosal T cells at different stages during their activation, differentiation as well as accumulation and maintenance in the lamina propria (LP).

The microbiota of patients with active Crohn’s disease (CD) and ulcerative colitis (UC), both forms of IBD, have increased abundance of Proteobacteria and lower faecal counts of Firmicutes compared to healthy individuals⁹. The Proteobacteria phylum includes pathobionts of Escherichia coli that contribute to the pathophysiology of the disease¹⁰. Among the Firmicutes, Faecalibacterium prausnitzii (Fp), one of the most abundant intestinal bacteria in humans¹¹,¹²,¹³, is reduced in CD and UC patients¹⁴,¹⁵. Fp strain A2-165 has been shown to attenuate colitis induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dinitrobenzenesulfonic acid (DNBS) in mice and to induce a relatively high IL-10 to IL-12p70 cytokine ratio in human peripheral blood mononuclear cells (hPBMCs)¹⁴,¹⁶. Fp along with certain members of the Clostridium cluster XIVa are prominent butyrate producers in the intestine¹⁷. Butyrate is a primary energy source for the epithelial cells lining the colon¹⁸ and appears to have both anti-inflammatory and cancer chemopreventive activities¹⁷,¹⁸,¹⁹.

DCs and T cells are instrumental in regulating tolerance and immunity in the intestinal mucosa but the effects of Fp on these cells have not yet been described. It is not known if the Fp strain A2-165 tested in the mouse colitis models is characteristic of other Fp strains or if responses differ to other members of Clostridium cluster IV and cluster XIVa isolated from the human colon. Furthermore, the mechanisms of the protective and anti-inflammatory effects of Fp have not yet been fully unravelled.

To address these questions, we have investigated and compared the immunomodulatory properties of Fp with other commensal bacteria on DCs and T cells in vitro. The immunomodulatory and TLR signalling properties of 13 commensal strains of the Firmicutes and Actinobacteria phyla, including five isolates of Fp were first evaluated using human monocyte-derived DCs (hDCs) and TLR expressing cell lines. Further immune response studies were then performed on a smaller number of strains using mouse bone marrow-derived DCs (BMDCs). Subsequently, Fp strain A2-165 and another butyrate producing Clostridium, Clostridium hathewayi (Ch) 82-B were tested in vivo for their anti-inflammatory effects in the DNBS model of chronic relapsing colitis and on mucosal T cell differentiation using a well characterized model for nasal tolerance induction to the antigen ovalbumin (OVA).

Results

Colonic bacteria of Clostridium clusters IV and XIVa induce differential cytokine responses in hDCs

Incubation of hDCs with the commensal bacteria (Table 1) induced hDC maturation and activation and increased surface expression of the markers CD83 and CD86 when compared with the control immature non-stimulated hDCs (Supplementary Fig. S1). Incubation with the bacteria did not significantly alter hDC viability compared to the unstimulated control cells (60–80% viability, not shown).

Table 1. Phylum, family and phylogenetic cluster of the bacteria used.

Bacterial strain	Phylum	Family	Phylogenetic cluster	Ref.
F. prausnitzii A2-165	Firmicutes	Ruminococcaceae	Clostr. cluster IV	12
F. prausnitzii M21/2	Firmicutes	Ruminococcaceae	Clostr. cluster IV	34
F. prausnitzii S3L/3	Firmicutes	Ruminococcaceae	Clostr. cluster IV	34
F. prausnitzii L2-6	Firmicutes	Ruminococcaceae	Clostr. cluster IV	12
F. prausnitzii HTF-F	Firmicutes	Ruminococcaceae	Clostr. cluster IV	2
R. bromii L2-63	Firmicutes	Ruminococcaceae	Clostr. cluster IV	13
E. rectale A1-86	Firmicutes	Lachnospiraceae	Clostr. cluster XIVa	13
E. hallii L2-7	Firmicutes	Lachnospiraceae	Clostr. cluster XIVa	35
B. adolescentis L2-32	Actinobacteria	Bifidobacteriaceae		13
Megamonas sp. Mag1B 95,0% homology* with M. rupellensis	Firmicutes	Veillonellaceae		This work
Clostridium sp. 82B 95,4% homology* with C. hathewayi	Firmicutes	Clostridiaceae	Clostr. cluster XIVa	This work
Clostridium sp. Lac1D 90,5% homology* with C. xylanovorans	Firmicutes	Clostridiaceae	Clostr. cluster XIVa	This work
L. plantarum WCFS1	Firmicutes	Lactobacillaceae

(Clostr, Clostridium); *based on the sequence homology of 850 nucleotides of the 16S rRNA.

Cytokines elicited by these strains result from the combination of TLR and NLR recognition of bacterial microbial associated molecular patterns (MAMPs) on the cell membrane as well as intra-cellularly after phagocytosis. Thus immune activation of hDCs was assessed by measuring the levels of IL-10, IL-12p70, IL-6, IL-1β and TNF-α secreted in the culture supernatant after incubation of the bacteria with hDCs from three to four different donors (Fig. 1). The largest amounts of IL-10 were induced by the Fp strains, Eubacterium hallii (Eh) L2-7 and Megamonas rupellenesis (Mr) Mag1B. In addition, these strains induced the largest amounts of TNF-α and IL-6. The Fp strains, Eh L2-7 and Eubacterium rectale (Er) A1-86 also induced relatively large amounts of IL-1β. Lactobacillus plantarum (Lp) WCFS1, Mr Mag1B and Eh L2-7 were among the most potent inducers of IL-12p70, whereas the Fp strains were among the poorer inducers (Fig. 1). Surprisingly, Ruminococcus bromii (Rb) L2-63, Ch 82-B and Clostridium xylanovorans (Cx) Lac1D induced small or undetectable amounts of some cytokines (Fig. 1) despite having effectively induced hDCs maturation (Supplementary Fig. S1). The five Fp strains had very different cytokines profiles. The highest IL-10 producer was strain A2-165, strains L2-6 and M21/2 induced high amounts of IL-10 but also IL-12p70 while strains S3L/3 and HTF-F induced intermediate to low amounts of both cytokines. The amounts of IL-10 induced by Fp strain A2-165 was 4.7 ng/ml in Donor 1, 1. 9 ng/ml in Donor 2 and 1.7 ng/ml in Donor 3. These amounts are relatively high compared to similar studies with probiotics and DCs or PBMCs²⁰,²¹.

Figure 1. Cytokine secretion by hDCs. IL-10, IL-12p70, TNF-α, IL-1β and IL-6 were measured in the supernatant of hDCs from 3 to 4 donors after 48 h of incubation with the bacteria (bacterium to DC ratio 10:1, 10⁶ DCs/well in 24w plate).

Each donor is represented with a different symbol and the red lines indicate the average of the donors.

Bacteria and hDCs were incubated in the presence of penicillin and streptomycin to prevent contaminations and bacterial overgrowth so no short-chain fatty acids or other metabolites would be produced. However, we independently tested whether the Fp A2-165 cell free culture supernatants, bacterial medium or butyrate at concentrations similar to that measured in the bacterial culture supernatant would activate hDCs. In an initial experiment, the bacterial supernatants were found to be toxic for the hDCs at a concentration of 10% v/v (data not shown). This toxicity can be attributed to the high concentration of butyrate produced during bacterial fermentation²². Fp A2-165 culture supernatant (1.25 and 2.5% v/v) and butyrate (25 to 500 μM) did not affect cell viability or cytokine secretion by hDCs compared to non-stimulated cells (data not shown).

Differential activation of TLRs by commensal bacteria

To investigate the potential relationship between cytokine profiles in hDCs and TLR signalling, bacteria were incubated with HEK293 reporter cell lines expressing different human TLRs and a reporter plasmid harbouring the luciferase gene under the control of the NF-κB promoter.

The Fp strains, Rb L2-63, Er A1-86, Eh L2-7 and Bifidobacterium adolescentis (Ba) L2-32 induced high NF-κB activation in the TLR2/6 and TLR2 reporter cell lines (Fig. 2). Agonists of TLR2 include acylated lipoprotein anchors and potentially lipoteichoic acid present in Gram-positive and Gram-negative bacterial envelopes. As previously reported²³, the flagellated strain Er A1-86²⁴ induced NF-κB activation via TLR5 signalling. Surprisingly, Eh L2-7 and Mr Mag1B activated TLR4 signalling although they are considered Gram-positive. Mr Mag1B however, has been described previously as Gram-negative to Gram-variable²⁵. Ch 82-B and Cx Lac1D did not induce NF-κB activation in any of the TLR assays. The relative capacity of the strains to elicit NF-κB activation through TLR signalling pathways correlated with the induction of cytokines in hDCs.

Figure 2. TLR signalling properties of the commensal bacteria. NF-κB activation was measured using a luminescence reporter in HEK293 cell lines expressing TLR2, TLR2/6, TLR5 and TLR4 after incubation with the bacteria (bacterium: cell ratio, 10:1).

NF-κB activation is expressed as percentage of the positive control. Error bars represent SEM, n = 6, *indicates p < 0.05, **p < 0.01, ***p < 0.001 compared to the control.

Principal component analysis

Principal component analysis (PCA) was performed to describe the variance of the cytokine levels (IL-10, IL-12p70, IL-6, IL-1β and TNF-α) induced by the bacteria after incubation with hDCs. The PC 1 and PC 2 of the PCA describe 99.9% of the variance between the cytokine levels induced by the bacteria. The coefficients of PC 1 revealed that the contribution of the different cytokines to the variance was almost equal, the coefficient associated with IL-12p70 was 0.2 while for the other cytokines the coefficient was in average 0.48. The PC 1, PC 2 score plot (Fig. 3) revealed that the majority of the bacteria are grouped in the centre of the plot, while Fp A2-165, Eh L2-7, Mr Mag1B and Lp WCFS1 are clearly separated from the other bacteria and from each other reflecting their capacity to induce distinct cytokine profiles in hDCs. Furthermore, PCA revealed that the immune response induced by Fp A2-165 is very different from the other Fp strains tested.

Figure 3. Principal component analysis (PCA) of the cytokine profiles induced by the commensal bacteria in hDCs.

Each dot represents the average of cytokine levels of a commensal strain in hDCs. The variables (level of cytokines) are represented by vectors. The direction and length of a vector indicates how the variable contributes to the two principal components in the plot. (F. prau, F. prausnitzii; R. brom, R. bromii L2-63; E. rect, E. rectale A1-86; E. hall, E. halli L2-7; M. rupe, M. rupellensis Mag1B; C. hath, C. hathewayi 82-B; C. xyla, C. xylanovorans Lac1D; L. plan, L. plantarum WCFS1).

Mouse BMDC cytokine responses to commensal bacteria

In order to select a strain to compare with Fp A2-165 in subsequent in vivo experiments, the immune response of mouse BMDCs incubated with Fp A2-165 and five other human commensal bacterial strains was measured. The candidate strains were chosen on the basis of cytokines produced in culture with hDCs. Fp A2-165 was the highest inducer of IL-10 release by hDCs, Ch 82-B and Cx Lac1D induced low or undetectable cytokine responses, Lp WCFS1 was one of the highest inducers of IL-12p70 release and Er A1-86 and Ba L2-32 induced intermediate levels of cytokines compared to the other strains (Fig. 1).

All the strains induced increased surface expression of the co-stimulatory molecules CD86 and CD40 by BMDCs compared to untreated BMDCs (Supplementary Fig. S2). Culture of BMDCs with Fp A2-165 induced the largest amount of IL-10 release, followed by Er A1-86 and Ba L2-32. IL-12p70 release by BMDCs was mostly induced by Fp A2-165 and Lp WCFS1. However, for all the strains tested the levels of IL-12p70 were around 10 fold lower than those obtained using hDCs (Fig. 4). The amounts of IFN-γ in the culture supernatants of stimulated BMDCs were low but high levels of TNF release were induced by virtually all bacterial strains with Lp WCFS1 and Fp A2-165 being the strongest inducers while Ch 82-B and Cx Lac1D were low to weak inducers. Ch 82-B was selected for comparison to Fp A2-165 in subsequent experiments in vitro and in vivo as it is capable of activating immune cells but a weak inducer of IL-10 and other cytokines.

Figure 4. Cytokine secretion by mouse BMDCs. IL-10, IL-12p70, TNF and IFN-γ were measured in the supernatant of BMDCs (5 × 10⁵ BMDCs/well in 24w plate) after 24 h of incubation with bacteria (bacterium: BMDC, 10:1).

Error bars represent SEM, n = 3, ***indicates p < 0.001, **p < 0.01, *p < 0.05 compared to the control.

F. prausnitzii A2-165 but not C. hathewayi 82-B attenuates inflammation in a chronic relapsing model of colitis

The capacity of Fp A2-165 to attenuate parameters of inflammatory colitis was investigated using a recently described model of chronic relapsing colitis¹⁶ and compared to the one of Ch 82-B. Ch 82-B was selected as it also produces butyrate but does not induce significant levels of IL-10 in BMDCs, or hDCs compared to Fp A2-165. Mice were administered a first dose of DNBS, and, after full recovery (day 10), were administered either Fp A2-165, Ch 82-B or ethanol intragastrically for other 10 days. On day 20 mice received a second lower dose of DNBS to induce a Th1-driven inflammatory response to the hapten. The weight loss of the Fp A2-165 treated mice was significantly smaller than the one of the DNBS control mice at the endpoint of the experiment (Fig. 5a). Additionally, the Fp A2-165 treated mice gained body weight significantly more rapidly than Ch 82B treated or DNBS control mice after the second administration of DNBS (Supplementary Fig. S4). In the Fp A2-165 treated mice, the macroscopic disease scores were significantly lower than in the DNBS control and in the Ch 82-B groups (Fig. 5b). Additionally, myeloperoxidase (MPO), an enzyme produced mainly by neutrophils and used as a marker of neutrophilic infiltration, was significantly lower in the Fp A2-165 treated group than in the other groups, suggesting reduced inflammatory responses leading to the recruitment of neutrophils (Fig. 5c). Fp A2-165 and Ch 82-B had no effect on histological damages (Fig. 5d).

Figure 5. Effects of F. prausnitzii A2-165 and C. hathewayi 82-B on DNBS induced colitis.

Percentage of weight loss at the end of the experiment (a), macroscopic scores (b), MPO activity (c) and histological scores (d) in control non-inflamed (PBS-Gly no DNBS), control inflamed (PBS-Gly), F. prausnitzii A2-165, C. hathewayi 82-B treated mice. Error bars represent SEM, n = 8, *indicates p < 0.05 compared to the control PBS-DNBS.

In vivo CD4⁺ T cell responses

To investigate whether the attenuation of certain disease scores in the DNBS model was due to the modulation of the mucosal T cell response by Fp A2-165, we used an in vivo model of nasal tolerance induction²⁶. Nasal tolerance is known to have many similarities to oral tolerance induction²⁶,²⁷ and application of bacteria via the nasal route effectively targets responses in the nose-draining CLNs. In short, BALB/c acceptor mice were adoptively transferred with CFSE labelled naive DO11.10 OVA T cell receptor (TCR) transgenic T cells and after 24 h, received an intranasal (i.n.) application of either the bacteria together with OVA or OVA alone. After 72 h, single cell suspensions isolated from CLNs and spleens were analysed to assess the proliferation and phenotype of OVA-specific T cells (OVA-T cells).

In Fp A2-165 treated mice, the percentage of dividing OVA-T cells in the CLNs was increased compared to the control mice administered OVA alone. In the spleen of control mice, that received OVA i.n., a population of OVA-T cells was found in the third, fourth or fifth division. In agreement with previous observations, no CFSE fluorescence was detected corresponding with T cells in first or second division. Therefore, this population reflects cells that have differentiated in the CLNs and entered the circulation upon exiting the CLNs. Administration of Fp A2-165 together with OVA significantly increased the number of divided OVA-T cells isolated from spleens compared to control mice (Fig. 6a and Supplementary Fig. S5). Together, these data demonstrate that i.n. administration of Fp A2-165 enhances the number of OVA-T cells that divide in the CLNs. In contrast, Ch 82-B administration significantly decreased the proliferation of OVA-T cells isolated from CLNs compared to the control and Fp A2-165 (Fig. 6a). This effect was also observed in a second independent experiment although the differences were not statistically significant (Supplementary Fig. S3). Increased numbers of divided OVA-T cells were not detected in the spleen of mice administered Ch 82-B (Fig. 6a).

Figure 6. Percentage of dividing and IFN-γ⁺ OVA-T cells in vivo.

CFSE labelled naive OVA-T cells (KJ1-26⁺/CD4⁺) were adoptively transferred in BALB/c mice, after 24 h, mice were administered i.n. with bacteria plus OVA and after additional 72 h, OVA-T cells were isolated from cervical lymph nodes (CLNs) and spleens and analysed. (a) Percentage of dividing OVA-T cells (KJ1-26⁺/CD4⁺) isolated from CLNs or spleens. (b) Percentage of IFN-γ⁺ OVA-T cells (KJ1-26⁺/CD4⁺) isolated from CLNs. *indicates p < 0.05, **indicates p < 0.01 compared to the control administered OVA alone.

I.n. administration of either Fp A2-165 or Ch 82-B together with OVA significantly decreased the number of IFN-γ secreting OVA-T cells isolated from the CLNs. In particular, Fp A2-165 induced an approximately three-fold reduction in the percentage of IFN-γ secreting cells (Fig. 6b). However, these bacteria did not affect the intracellular expression of Foxp3, IL-17, or IL-10 in OVA-T cells isolated from the CLNs (not shown).

Overall re-stimulation of CLN cells led to low and variable levels of cytokine release. This is likely to be due to the low frequency of OVA-T cells within the total CLN cell population. Notably, CLN cells of Ch 82-B treated mice released lower amounts of cytokines but this was only significant for IL-10 and MCP-1 (Fig. 7).

Figure 7. Cytokine secretion by OVA-T cells after ex vivo re-stimulation.

CFSE labelled naive OVA-T cells were adoptively transferred in BALB/c mice, after 24 h, mice were administered i.n. with bacteria plus OVA and after additional 72 h, OVA-T cells were isolated from CLNs and re-stimulated with OVA for additional 24 h and then analysed. *indicates p < 0.05 compared to the control administered OVA alone.

Effects of F. prausnitzii A2-165 and C. hathewayi 82-B on T cell differentiation in BMDC-T cell co-cultures

In order to investigate whether the effects of Fp A2-165 and Ch 82-B on activation, differentiation and modulation of T cell responses in vivo could be observed in an in vitro assay we cultured BMDCs in the presence or absence of the bacteria or LPS for 24 h and then OVA was added for a further 6 h. Finally, naive CFSE labelled CD4⁺ OVA-T cells were added for an additional 72 h.

All conditions of BMDC stimulation increased the number of OVA-T cells undergoing proliferation compared to the unstimulated BMDC control. No significant differences in the percentage of dividing T cells were observed between BMDC stimulation with LPS, Fp A2-165 or Ch 82-B (Fig. 8a and Supplementary Fig. S6).

Figure 8. OVA-T cells (KJ1-26⁺/CD4⁺) division (a), IFN-γ⁺, IL-17⁺, Foxp3⁺ cells (b) and cytokine secretion (c) after incubation with BMDCs pre-stimulated with bacteria (bacterium: BMDC, 10: 1).

BMDCs (5 × 10⁴ BMDCs/well in 96w plate) were loaded with OVA (0.5 mg/ml) and cultured in the presence or absence of the bacteria or LPS and after 24 h, CFSE labelled OVA-T cells (5 × 10⁵ T cells/well) were added, after 72 h cytokine secretion in the supernatant and intracellular markers were measured. Error bars represent SEM, n = 3, *** indicates p < 0.001 compared to the control, *p < 0.05 compared to the control. Intracellular IL-10 staining was negative for all samples.

As observed in vivo the intracellular staining of OVA-T cells revealed that Fp A2-165 decreased the percentage of total IFN-γ⁺ T cells compared to the control but had no effect on IL-17⁺ and Foxp3⁺ T cells (Fig. 8b). Notably, BMDCs pre-incubated with Fp A2-165 induced increased IL-10 secretion during OVA-T cell proliferation (Fig. 8c) compared to the control. However, no significant changes were observed in the amounts of IFN-γ and IL-17 in any of the culture supernatants compared to the control (Fig. 8c). None of the bacteria altered the levels of secreted IL-2, IL-6 or TNF compared to the control (not shown). In contrast to Fp, Ch 82-B induced an increase in the percentage of IFN-γ⁺, IL-17⁺ and Foxp3⁺ T cells compared to the control (Fig. 8b) which is not consistent with results with this strain in vivo. It may be that the in vitro immune assays are not predictive for the complex situation in vivo where stromal cytokines and factors also influence APC phenotypes. Another possibility is that this inconsistency is due to the fact that Ch 82-B possesses almost no TLR signalling activity (Fig. 2) but can strongly activate hDCs and BMDCs in vitro (Supplementary Fig. S1 and S2) resulting in no or low amounts of cytokine secretion. Thus activation of hDCs and BMDCs by Ch 82-B is presumably the consequence of phagocytosis and intracellular NLR activation.

Discussion

Members of the Firmicutes, including members of the Clostridium clusters IV and XIVa, are reduced in abundance in the fecal microbiota of IBD patients²⁸,²⁹. Additionally, mucosal abundance of Fp, a member of Clostridium cluster IV, has been correlated with increased recurrence of colitis in CD patients¹⁴. Fp strain A2-165 and its culture supernatant were previously shown to attenuate colitis in mouse models. The incubation of hPBMCs with Fp A2-165 induced a relatively high IL-10 to IL-12p70 cytokine ratio, suggesting that the bacterium might have an effect on DCs and induction of T cells in the mucosal lymphoid tissue¹⁴,¹⁶. Furthermore, IL-10 produced by APCs in the LP has been reported to enhance the suppressive activity of Foxp3⁺ Tregs in the mucosa³⁰.

We investigated the immunomodulatory properties of five Fp strains and eight other abundant intestinal commensal bacteria of Clostridium clusters IV and XIVa. Other Clostridia, when administered as a spore preparation have been shown to induce the expansion and activation of Tregs after colonization of germ-free mice³¹. All the bacteria tested were able to induce efficient maturation and activation of hDCs (Supplementary Fig. S1). In hDCs, the highest levels of IL-10 were induced by Fp A2-165, Eh L2-7 and Mr Mag1B. Fp A2-165 was among the weakest inducers of IL-12p70 while Mr Mag1B and Eh L2-7 were among the strongest inducers. Additionally, these strains induced the largest amounts of TNF-α and IL-6. The Fp strains, Eh L2-7 and Er A1-86 induced also relatively large amounts of IL-1β (Fig. 1). PCA revealed that Fp A2-165, Mr Mag1B and Eh L2-7 cause distinct effects on the immune cells when compared to the other strains. These differential effects were due to the high levels of IL-10 induced by Fp A2-165, the high levels of IL-12p70 and TNF-α induced by Mr Mag1B and the high levels of IL-10 and IL-12p70 induced by Eh L2-7. Furthermore, Fp A2-165 is separated from the other Fp strains (Fig. 3).

In general, high TLR signalling activity was associated with the ability of commensal bacteria to induce cytokines in the DC assays. TLR4 signalling was induced by Eh L2-7 and Mr Mag1B, belonging to the Firmicutes lineage of bacteria, which are generally considered as Gram-positive. However, due to their unique cell wall composition, upon Gram staining these bacteria appeared to be Gram-negative to Gram-variable²⁴,²⁵. Ch 82-B and Cx Lac1D induced low NF-κB activation in the TLR assays and low or undetectable cytokines in the DC assay (Figs 1 and 2) despite the fact that they induced activation and maturation of DCs (Supplementary Fig. S1). These strains might express MAMPs that are shielded or not recognized by the TLRs tested or might possess immunomodulatory components that inhibit activation of the NF-κB pathway. This appears to be a unique property and may be an evolutionary adaptation to avoid immune recognition by the host as proposed for Bacteroides fragilis³².

Fp A2-165 has been previously reported to be anti-inflammatory and attenuate inflammation in mouse models of colitis¹⁴,¹⁶, therefore we compared its protective effects in the DNBS model of chronic relapsing colitis with that of Ch 82-B, a butyrate producing organism that induces only low amounts of IL-10 secretion in hDCs and BMDCs. In the Fp A2-165 treated mice, body weight loss, tissue MPO and macroscopic disease scores were attenuated compared to the control and Ch 82-B groups (Fig. 5). To investigate whether the attenuation of inflammation parameters in the DNBS model was due to modulation of the mucosal T cell response by Fp A2-165, we i.n. inoculated OVA or OVA together with the bacteria into BALB/c mice adoptively transferred with naive OVA-TCR transgenic T cells. After 72 h, single cell suspensions isolated from CLNs and spleens were analysed to assess the proliferation and phenotype of OVA-T cells. Fp A2-165 enhanced the number of OVA-T cells that divide in the CLNs and decreased the percentage of IFN-γ secreting T cells (Fig. 6). The effects of Fp on T cell differentiation in vivo may be due to the uptake of bacteria or microbial factors (including MAMPs) resulting in increased DC activation as seen in the in vitro experiments (Supplementary Fig. S1 and S2). The activated DCs may then migrate from PPs or LP to drive enhanced antigen presentation of OVA in the CLNs. Although Fp A2-165 administration increased the percentage of dividing T cells in vivo, it decreased the percentage of IFN-γ⁺ T cells without affecting Foxp3⁺ or IL-17⁺ T cells (Fig. 6). This finding suggests that Fp A2-165 modulated the phenotype of mucosal DCs that migrate from the LP to suppress IFN-γ differentiation in the draining CLNs. Unfortunately we were not able to detect intracellular IL-10 staining in CLNs cells. IL-10 may suppress differentiation of IFN-γ secreting cells in the CLNs once the cells have proliferated and re-express their IL-10R. Future experiments using in vivo blocking with anti-IL-10R antibodies would provide an answer to this hypothesis.

Strikingly, the effects of Fp A2-165 on T cell proliferation and differentiation of IFN-γ secreting T cells in vivo were also observed in vitro using Fp A2-165 stimulated BMDCs co-cultured with naive D011.10 T cells. In these co-cultures, secretion of IL-10 was significantly higher than the control when the BMDCs were pre-stimulated with Fp A2-165 but not with other stimuli (Fig. 8). The concomitant enhanced proliferation and high levels of IL-10 secretion in BMDC-T cell co-cultures may seem counter intuitive as IL-10 is known to suppress T cell proliferation. However, the onset of T cell proliferation may not be sensitive to IL-10 suppression because the cells down regulate expression of the IL-10Rα chain³³.

In contrast to Fp A2-165, Ch 82-B reduced the number of proliferating OVA-T cells in the CLNs in vivo (Fig. 6). This finding was in contrast to the in vitro results showing that Ch 82-B stimulated BMDCs were highly effective in stimulating T cell proliferation. Indeed, the percentage of T cells staining positive for intracellular markers of different T cell subsets (i.e. IFN-γ, IL-17 and Foxp3) were significantly higher for T cells incubated with BMDCs pre-stimulated with Ch 82-B than BMDCs pre-stimulated with Fp A2-165, LPS or left unstimulated (Fig. 8). The reasons for this are not clear but may be due to inhibitory effects of Ch on the migration of DCs from the mucosa to the draining lymph nodes, which is not mimicked in vitro.

In conclusion, we demonstrated that Fp A2-165 has a strong capacity to induce IL-10 in human and murine DCs and influence T cell differentiation in vitro and in vivo. The reduction in IFN-γ⁺ cells in vivo and the IL-10 induction in the LP cells of damaged intestinal tissue could be a mechanisms contributing to the suppressive effect on inflammation in mouse colitis models¹⁴,¹⁶. Moreover, these findings suggest that this normally abundant bacterium might contribute to immune homeostasis in the intestine via its anti-inflammatory properties.

Materials and Methods

Bacterial strains and culturing conditions

All the commensal bacteria used (Table 1) were isolated from human faeces and identified by 16S rRNA sequencing as previously described². L. plantarum WCFS1 was isolated from human saliva. The commensal bacteria were maintained at 37 °C on YCFAG in an anaerobic tent. Bacteria were grown in YCFAG broth to an optical density at 600 nm (A600) of 0.8, which corresponds to the late exponential or early stationary growth phase. L. plantarum WCFS1 was cultured overnight to stationary phase in MRS broth (MRS, Merck, Darmstadt, Germany) at 37 °C. Bacteria were harvested by centrifugation, washed in PBS, resuspended in PBS containing 20% glycerol and stored at −80 °C prior to use in the assays. Bacteria were quantified by fluorescent in situ hybridization (FISH) or phase contrast microscopy. All buffers and media used for the anaerobic bacteria were deoxygenated by flushing with oxygen free nitrogen for 30 minutes.

Human DCs assays

This study was approved by Wageningen University Ethical Committee and was conducted in accordance with the principles of the ‘Declaration of Helsinki’ (52nd WMA General Assembly, Edinburgh, Scotland, October 2000). Buffy coats from healthy blood donors were obtained from the Sanquin Blood bank in Nijmegen (The Netherlands). A written informed consent was obtained from each volunteer before sample collection. See Supplementary Methods.

TLR signalling assays

See Supplementary Methods.

Mice

For the DNBS induced colitis, animal experiments were approved by the Ethic Committee of Jouy en Josas research centre. Male C57BL/6 mice (6 weeks old) were purchased from Janvier Labs and maintained at the animal facility under specific pathogen-free conditions. Mice were housed under standard conditions for a minimum of 1 week before experimentation.

For the in vivo nasal tolerance and the in vitro BMDCs and T cells assays, animal experiments were approved by the Animal Experimental Committee of the Erasmus Medical Centre. BALB/c mice were obtained from Charles River Laboratories (Maastricht, The Netherlands) and kept in the Erasmus University Medical Centre. DO11.10 transgenic mice on BALB/c background, which have a T cell receptor (TCR) specific for the OVA 323-339 peptide, were bred at the Erasmus University Medical Centre. Mice were kept under specific pathogen-free housing conditions.

Animals were handled in accordance with the general principles and guidelines recommended by the European Community (Directive 86/609/EEC) and current French legislation (Law 87–848) or Dutch legislation (The Experiments on Animals Act, 1997).

Mouse BMDCs assays

See Supplementary Methods.

Induction of DNBS colitis and bacteria administration

The DNBS induced chronic colitis model was described by Martin et al.¹⁶. Briefly, mice were anesthetized and a 4 cm long catheter (Ecimed, France) was attached to a 1 ml-syringe and inserted 3.5 cm into the colon. Colitis was induced by intrarectal injection of 150 mg/kg of DNBS solution (Sigma) in 30% ethanol (EtOH). Control mice (that did not develop colitis) received only EtOH. Mice were supplied with 6% sucrose in the drinking water for the first 3 days after DNBS injection to prevent dehydration (DNBS period). Ten days following DNBS injection, 200 μL containing either 1 × 10⁹ bacteria or 200 μL of PBS were administered intragastrically daily for 10 days. Colitis was reactivated 21 days after the first DNBS injection (recovery period) with a second injection of 150 mg/kg of DNBS solution, control mice received only EtOH. Mice weight was recorded through all the experiment, each group consisted of 8 mice.

Macroscopic scores, colonic histology and myeloperoxidase activity

Severity of colitis was determined as previously described¹⁶. See Supplementary Methods.

Purification of DO11.10 T-cells

See Supplementary Methods.

In vitro assays with DO11.10 T cells

See Supplementary Methods.

Adoptive transfer of DO11.10 T cells and intranasal challenge

For the in vivo nasal tolerance study, acceptor BALB/c mice received 6 × 10⁶ CFSE labelled KJ1-26⁺ CD4⁺ T cells in 200 μl saline (NaCl 0.9%, Brown) by injection in the tail vein. DO11.10xRag-/- T cells were isolated as described above. Twenty-four h after the adoptive transfer, mice were administered i.n. with 2 × 10⁸ bacteria in 15 μl of saline containing 400 μg of OVA or 15 μl of saline with OVA as a control. Throughout the in vivo experiment, groups of mice that received different treatments were housed separately. After 72 h, mice were sacrificed, nose-draining superficial and deep cervical lymph nodes (CLNs) and spleens were collected and single cell suspensions were analysed by flow cytometry for cell division and stained for surface or intracellular protein detection or used for ex vivo T-cells restimulation.

Ex vivo DO11.10 T-cell restimulation

See Supplementary Methods.

Flow cytometry

See Supplementary Methods.

Statistics and principal component analysis

Differences in NF-κB activation in the TLR assays, cytokine secretion, surface marker expression and percentage of dividing or positive cells were analysed comparing samples treated with the bacteria or LPS with the untreated control. Data were analysed by one way Anova followed by Dunnett’s multiple comparison test for the in vitro assays or Newman-Keuls multiple comparison test for the in vivo assays using the GraphPad PRISM (GraphPad Software). PCA was used to analyse the variance of the level of cytokines along the different types of bacteria studied. PCA was computed on the standardized data by using the function princomp of the software Matlab.

Additional Information

How to cite this article: Rossi, O. et al. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci. Rep. 6, 18507; doi: 10.1038/srep18507 (2016).